跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARMUSTINA HIKMA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CARMUSTINA HIKMA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Approved
STANDARD
CARMUSTINA HIKMA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Hikma Farmaceutica (Portugal) S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 19, 2024
Approval ID
25fff803b6ddcdcf
Company
Hikma Farmaceutica (Portugal) S.A.
Type
Standard
Approval Details
Approval Id
25fff803b6ddcdcf
Drug Cima Aemps Name
CARMUSTINA HIKMA 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Register Number
89362
Holder Company Name
Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name
Hikma España, S.L.U.
Holder Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Authorization Date
2024-02-19
Dosage Form
POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Hikma Farmaceutica (Portugal) S.A.
Company Detail Path
/organization/hikma-farmaceutica-portugal-s-a
Company Information
Pharmaceutical Company Name
HIKMA FARMACÊUTICA (PORTUGAL), S.A.
Country Name
Portugal
City Name
terrugem snt,lisboa,country_pt
Address
ESTRADA RIO DA MÓ, 8/8A/B
Active Ingredients
CARMUSTINA
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 19, 2024
Approval ID
25fff803b6ddcdcf
Type
Standard
Back to CIMA-AEMPS Approvals